Black Rock Inc. Tela Bio, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Tela Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,043,228 shares of TELA stock, worth $4.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,043,228

Previous 1,078,056 3.23%

Holding current value

$4.9 Million

Previous $7.14 Million 17.11%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$5.3 - $7.61 $184,588 - $265,041	-34,828 Reduced 3.23%	1,043,228 $5.92 Million
Q4 2023 Feb 13, 2024	BUY	$4.5 - $7.51 $261,081 - $435,715	58,018 Added 5.69%	1,078,056 $7.14 Million
Q3 2023 Nov 13, 2023	BUY	$7.85 - $10.68 $66,842 - $90,940	8,515 Added 0.84%	1,020,038 $8.16 Million
Q2 2023 Aug 11, 2023	BUY	$9.23 - $11.23 $9.17 Million - $11.2 Million	992,960 Added 5349.14%	1,011,523 $10.2 Million
Q1 2023 May 12, 2023	SELL	$9.41 - $12.03 $301 - $384	-32 Reduced 0.17%	18,563 $197,000

Q4 2022 Feb 13, 2023	BUY	$6.5 - $11.5 $9,048 - $16,008	1,392 Added 8.09%	18,595 $213,000
Q3 2022 Nov 14, 2022	BUY	$7.36 - $9.15 $18,974 - $23,588	2,578 Added 17.63%	17,203 $146,000
Q2 2022 Aug 12, 2022	SELL	$5.54 - $11.49 $37,660 - $78,109	-6,798 Reduced 31.73%	14,625 $103,000
Q1 2022 May 12, 2022	SELL	$11.35 - $13.7 $10,998 - $13,275	-969 Reduced 4.33%	21,423 $249,000
Q4 2021 Feb 10, 2022	BUY	$11.95 - $13.34 $10,587 - $11,819	886 Added 4.12%	22,392 $287,000
Q3 2021 Nov 09, 2021	SELL	$12.2 - $15.93 $4,684 - $6,117	-384 Reduced 1.75%	21,506 $294,000
Q2 2021 Aug 11, 2021	BUY	$11.7 - $16.11 $256,112 - $352,647	21,890 New	21,890 $352,000

Others Institutions Holding TELA

# of Institutions

Shares Held

20.8M

Call Options Held

200

Put Options Held

1.3K

View Full List

About TELA Bio, Inc.

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $90M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

More about TELA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account